KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2025)

Bionano Genomics (BNGO) has disclosed Return on Invested Capital for 8 consecutive years, with 0.11% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 40.0% to 0.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.11% through Dec 2025, up 40.0% year-over-year, with the annual reading at 0.13% for FY2025, 21.0% up from the prior year.
  • Return on Invested Capital hit 0.11% in Q4 2025 for Bionano Genomics, down from 0.85% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.85% in Q3 2025 to a low of 2.23% in Q1 2024.
  • Historically, Return on Invested Capital has averaged 0.62% across 5 years, with a median of 0.38% in 2022.
  • Biggest five-year swings in Return on Invested Capital: plummeted -166bps in 2024 and later skyrocketed 256bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.21% in 2021, then crashed by -137bps to 0.5% in 2022, then tumbled by -290bps to 1.93% in 2023, then soared by 73bps to 0.51% in 2024, then skyrocketed by 78bps to 0.11% in 2025.
  • Business Quant data shows Return on Invested Capital for BNGO at 0.11% in Q4 2025, 0.85% in Q3 2025, and 0.17% in Q2 2025.